•
Dec 31, 2023

Belite Bio Q4 2023 Earnings Report

Total Revenue
$0
EPS
-$0.25
Previous year: -$0.63
-60.3%
R&D Expenses
$4.86M
General & Admin Expenses
$2.09M
Gross Profit
$0
Cash and Equivalents
$88.2M
Previous year: $42.1M
+109.5%
Free Cash Flow
-$29.9M
Previous year: -$11.9M
+152.3%
Total Assets
$94.6M
Previous year: $44.3M
+113.8%

Belite Bio

Belite Bio